Reuters logo
BRIEF-Ani Pharmaceuticals pays about $20 mln in consideration for acquisition of Cranford assets
February 24, 2017 / 1:45 PM / 10 months ago

BRIEF-Ani Pharmaceuticals pays about $20 mln in consideration for acquisition of Cranford assets

Feb 24 (Reuters) - Ani Pharmaceuticals Inc

* Ani Pharmaceuticals Inc - in consideration for acquisition of Cranford assets, company paid a purchase price of approximately $20 million - SEC filing

* Ani Pharmaceuticals Inc- in consideration for acquisition of Holmdel assets, company paid a purchase price of approximately $31 million - sec filing Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below